Concepedia

Ahmed M. Abdelhady

AM

Statistics

Publications

10

Citations

307

H-Index

10

Active since

2016

Affiliations

Novartis (Switzerland)(Current)

University of Chicago

Novartis (United States)

Medical University of Vienna

Hôpital Maisonneuve-Rosemont

Ahmed M. Abdelhady is an author at Novartis (Switzerland) specializing in medicine, cancer research, and oncology.

ORCID

Top concepts

Publications per year

2016–2024

10

Publications

10

CRISPR-Cas9 In Vivo Gene Editing of <i>KLKB1</i> for Hereditary Angioedema

Hilary Longhurst, Karen Lindsay, Remy S. Petersen et al. · New England Journal of Medicine · 2024 · 142 citations

CRISPR-Based Therapy for Hereditary Angioedema

Danny M. Cohn, Padmalal Gurugama, Markus Magerl et al. · New England Journal of Medicine · 2024 · 36 citations

Losartan may inhibit the progression of liver fibrosis in chronic HCV patients

Zakaria A. Salama, Ahmed Sadek, Ahmed M. Abdelhady et al. · HepatoBiliary Surgery and Nutrition · 2016 · 31 citations · Full text

Portia: A Phase 1b Study Evaluating Safety and Efficacy of Tisagenlecleucel and Pembrolizumab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Ulrich Jaeger, Nina Worel, Joseph P. McGuirk et al. · Blood · 2019 · 21 citations

Evaluation of Absolute Oral Bioavailability and Bioequivalence of Ribociclib, a Cyclin‐Dependent Kinase 4/6 Inhibitor, in Healthy Subjects

Yan Ji, Ahmed M. Abdelhady, Tanay S. Samant et al. · Clinical Pharmacology in Drug Development · 2020 · 19 citations

, , +15

1–5 of 10